Bicker J - Search Results

1

Licochalcone A: A Potential Multitarget Drug for Alzheimer's Disease Treatment.

Olloquequi J, Ettcheto M, Cano A, Fortuna A, Bicker J, Sánchez-Lopez E, Paz C, Ureña J, Verdaguer E, Auladell C, Camins A. Olloquequi J, et al. Among authors: bicker j. Int J Mol Sci. 2023 Sep 16;24(18):14177. doi: 10.3390/ijms241814177. Int J Mol Sci. 2023. PMID: 37762479 Free PMC article. Review.

2

A chiral HPLC-UV method for the quantification of dibenz[b,f]azepine-5-carboxamide derivatives in mouse plasma and brain tissue: eslicarbazepine acetate, carbamazepine and main metabolites.

Fortuna A, Bicker J, Alves G, Falcão A, Soares-da-Silva P. Fortuna A, et al. Among authors: bicker j. J Sep Sci. 2011 Jun;34(12):1391-401. doi: 10.1002/jssc.201100099. Epub 2011 May 9. J Sep Sci. 2011. PMID: 21557472

3

Liquid chromatographic methods for the quantification of catecholamines and their metabolites in several biological samples--a review.

Bicker J, Fortuna A, Alves G, Falcão A. Bicker J, et al. Anal Chim Acta. 2013 Mar 20;768:12-34. doi: 10.1016/j.aca.2012.12.030. Epub 2012 Dec 27. Anal Chim Acta. 2013. PMID: 23473246 Review.

4

Blood-brain barrier models and their relevance for a successful development of CNS drug delivery systems: a review.

Bicker J, Alves G, Fortuna A, Falcão A. Bicker J, et al. Eur J Pharm Biopharm. 2014 Aug;87(3):409-32. doi: 10.1016/j.ejpb.2014.03.012. Epub 2014 Mar 28. Eur J Pharm Biopharm. 2014. PMID: 24686194 Review.

5

A new PAMPA model using an in-house brain lipid extract for screening the blood-brain barrier permeability of drug candidates.

Bicker J, Alves G, Fortuna A, Soares-da-Silva P, Falcão A. Bicker J, et al. Int J Pharm. 2016 Mar 30;501(1-2):102-11. doi: 10.1016/j.ijpharm.2016.01.074. Epub 2016 Feb 1. Int J Pharm. 2016. PMID: 26836708

6

Screening of pharmacokinetic properties of fifty dihydropyrimidin(thi)one derivatives using a combo of in vitro and in silico assays.

Matias M, Fortuna A, Bicker J, Silvestre S, Falcão A, Alves G. Matias M, et al. Among authors: bicker j. Eur J Pharm Sci. 2017 Nov 15;109:334-346. doi: 10.1016/j.ejps.2017.08.023. Epub 2017 Aug 24. Eur J Pharm Sci. 2017. PMID: 28842351

7

Elucidation of the Impact of P-glycoprotein and Breast Cancer Resistance Protein on the Brain Distribution of Catechol-O-Methyltransferase Inhibitors.

Bicker J, Fortuna A, Alves G, Soares-da-Silva P, Falcão A. Bicker J, et al. Drug Metab Dispos. 2017 Dec;45(12):1282-1291. doi: 10.1124/dmd.117.077883. Epub 2017 Sep 15. Drug Metab Dispos. 2017. PMID: 28916530

8

In vitro assessment of the interactions of dopamine β-hydroxylase inhibitors with human P-glycoprotein and Breast Cancer Resistance Protein.

Bicker J, Alves G, Fortuna A, Soares-da-Silva P, Falcão A. Bicker J, et al. Eur J Pharm Sci. 2018 May 30;117:35-40. doi: 10.1016/j.ejps.2018.02.006. Epub 2018 Feb 8. Eur J Pharm Sci. 2018. PMID: 29428540

9

Development and full validation of an innovative HPLC-diode array detection technique to simultaneously quantify lacosamide, levetiracetam and zonisamide in human plasma.

Gonçalves J, Alves G, Bicker J, Falcão A, Fortuna A. Gonçalves J, et al. Among authors: bicker j. Bioanalysis. 2018 Apr 1;10(8):541-557. doi: 10.4155/bio-2017-0199. Epub 2018 Mar 21. Bioanalysis. 2018. PMID: 29561632

10

Relevance of Breast Cancer Resistance Protein to Brain Distribution and Central Acting Drugs: A Pharmacokinetic Perspective.

Goncalves J, Bicker J, Alves G, Fortuna A, Falcao A. Goncalves J, et al. Among authors: bicker j. Curr Drug Metab. 2018;19(12):1021-1041. doi: 10.2174/1389200219666180629121033. Curr Drug Metab. 2018. PMID: 29956624 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters